Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00265304 · ClinicalTrials.gov registry record · Phase 2
A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee
A Phase 2 study, sponsored by IDEA.
- Completed
- Registry status
- Phase 2
- Development phase
- 550
- Enrollment target
NCT00265304 is a Phase 2 study that has completed, run by IDEA. The registered enrollment target is 550 participants.
The verdict
NCT00265304, a Phase 2 study, has completed, sponsored by IDEA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 550 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.
Interventions
- DRUG Ketoprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00265304
The ClinicalTrials.gov registry entry for NCT00265304 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IDEA, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketoprofen is the first listed.
NCT00265304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00265304 about?
NCT00265304 is a clinical study titled "A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.
What is the current status of trial NCT00265304?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 550 participants. The study started on 2005-07.
What interventions are being tested in trial NCT00265304?
The interventions under investigation include: Ketoprofen (DRUG).
Who is sponsoring clinical trial NCT00265304?
This trial is sponsored by IDEA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.